vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.

ACACIA RESEARCH CORP is the larger business by last-quarter revenue ($50.1M vs $31.1M, roughly 1.6× LIFECORE BIOMEDICAL, INC. \DE\). ACACIA RESEARCH CORP runs the higher net margin — 6.8% vs -32.1%, a 38.9% gap on every dollar of revenue. On growth, ACACIA RESEARCH CORP posted the faster year-over-year revenue change (2.6% vs -4.5%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs -0.1%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

ACTG vs LFCR — Head-to-Head

Bigger by revenue
ACTG
ACTG
1.6× larger
ACTG
$50.1M
$31.1M
LFCR
Growing faster (revenue YoY)
ACTG
ACTG
+7.1% gap
ACTG
2.6%
-4.5%
LFCR
Higher net margin
ACTG
ACTG
38.9% more per $
ACTG
6.8%
-32.1%
LFCR
Faster 2-yr revenue CAGR
ACTG
ACTG
Annualised
ACTG
43.6%
-0.1%
LFCR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ACTG
ACTG
LFCR
LFCR
Revenue
$50.1M
$31.1M
Net Profit
$3.4M
$-10.0M
Gross Margin
12.8%
25.0%
Operating Margin
-26.1%
-9.9%
Net Margin
6.8%
-32.1%
Revenue YoY
2.6%
-4.5%
Net Profit YoY
125.5%
-52.0%
EPS (diluted)
$0.03
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
LFCR
LFCR
Q4 25
$50.1M
Q3 25
$59.4M
$31.1M
Q2 25
$51.2M
Q1 25
$124.4M
$35.2M
Q4 24
$48.8M
$32.6M
Q3 24
$23.3M
$24.7M
Q2 24
$25.8M
Q1 24
$24.3M
$35.7M
Net Profit
ACTG
ACTG
LFCR
LFCR
Q4 25
$3.4M
Q3 25
$-2.7M
$-10.0M
Q2 25
$-3.3M
Q1 25
$24.3M
$-14.8M
Q4 24
$-13.4M
$-6.6M
Q3 24
$-14.0M
$-16.2M
Q2 24
$-8.4M
Q1 24
$-186.0K
$15.6M
Gross Margin
ACTG
ACTG
LFCR
LFCR
Q4 25
12.8%
Q3 25
21.2%
25.0%
Q2 25
12.8%
Q1 25
47.4%
28.0%
Q4 24
17.6%
34.0%
Q3 24
10.1%
21.8%
Q2 24
26.2%
Q1 24
49.2%
33.3%
Operating Margin
ACTG
ACTG
LFCR
LFCR
Q4 25
-26.1%
Q3 25
-10.8%
-9.9%
Q2 25
-24.2%
Q1 25
30.8%
-25.7%
Q4 24
-32.4%
-6.0%
Q3 24
-44.1%
-46.9%
Q2 24
-18.4%
Q1 24
-8.6%
-2.5%
Net Margin
ACTG
ACTG
LFCR
LFCR
Q4 25
6.8%
Q3 25
-4.6%
-32.1%
Q2 25
-6.4%
Q1 25
19.5%
-42.0%
Q4 24
-27.5%
-20.2%
Q3 24
-60.0%
-65.7%
Q2 24
-32.7%
Q1 24
-0.8%
43.8%
EPS (diluted)
ACTG
ACTG
LFCR
LFCR
Q4 25
$0.03
Q3 25
$-0.03
$-0.29
Q2 25
$-0.03
Q1 25
$0.25
$-0.47
Q4 24
$-0.14
$-0.25
Q3 24
$-0.14
$-0.53
Q2 24
$-0.08
Q1 24
$0.00
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
LFCR
LFCR
Cash + ST InvestmentsLiquidity on hand
$306.7M
$18.9M
Total DebtLower is stronger
$91.9M
$136.0M
Stockholders' EquityBook value
$543.5M
$-10.5M
Total Assets
$771.0M
$235.2M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
LFCR
LFCR
Q4 25
$306.7M
Q3 25
$301.8M
$18.9M
Q2 25
$316.7M
Q1 25
$272.0M
$5.4M
Q4 24
$273.9M
$9.5M
Q3 24
$410.9M
Q2 24
$441.9M
Q1 24
$498.4M
Total Debt
ACTG
ACTG
LFCR
LFCR
Q4 25
$91.9M
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q2 24
Q1 24
$97.1M
Stockholders' Equity
ACTG
ACTG
LFCR
LFCR
Q4 25
$543.5M
Q3 25
$537.6M
$-10.5M
Q2 25
$538.6M
Q1 25
$540.2M
$2.2M
Q4 24
$514.8M
$15.4M
Q3 24
$540.2M
$-3.9M
Q2 24
$560.7M
Q1 24
$568.3M
$17.7M
Total Assets
ACTG
ACTG
LFCR
LFCR
Q4 25
$771.0M
Q3 25
$768.9M
$235.2M
Q2 25
$775.5M
Q1 25
$801.6M
$237.7M
Q4 24
$756.4M
$255.4M
Q3 24
$707.6M
$246.8M
Q2 24
$753.6M
Q1 24
$631.7M
$246.2M
Debt / Equity
ACTG
ACTG
LFCR
LFCR
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q2 24
Q1 24
5.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
LFCR
LFCR
Operating Cash FlowLast quarter
$75.2M
$1.8M
Free Cash FlowOCF − Capex
$25.0K
FCF MarginFCF / Revenue
0.1%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
22.01×
TTM Free Cash FlowTrailing 4 quarters
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
LFCR
LFCR
Q4 25
$75.2M
Q3 25
$9.5M
$1.8M
Q2 25
$50.1M
Q1 25
$2.4M
$1.2M
Q4 24
$50.1M
$-6.1M
Q3 24
$-593.0K
$-613.0K
Q2 24
$16.1M
Q1 24
$54.8M
$-1.4M
Free Cash Flow
ACTG
ACTG
LFCR
LFCR
Q4 25
Q3 25
$25.0K
Q2 25
Q1 25
$335.0K
$-4.3M
Q4 24
$-98.5M
$-8.6M
Q3 24
$-2.8M
$-4.0M
Q2 24
$-126.7M
Q1 24
$54.6M
$-7.8M
FCF Margin
ACTG
ACTG
LFCR
LFCR
Q4 25
Q3 25
0.1%
Q2 25
Q1 25
0.3%
-12.1%
Q4 24
-201.8%
-26.3%
Q3 24
-12.1%
-16.3%
Q2 24
-490.5%
Q1 24
224.4%
-21.8%
Capex Intensity
ACTG
ACTG
LFCR
LFCR
Q4 25
Q3 25
5.6%
Q2 25
Q1 25
1.7%
15.5%
Q4 24
304.4%
7.5%
Q3 24
9.6%
13.9%
Q2 24
553.0%
Q1 24
1.1%
17.8%
Cash Conversion
ACTG
ACTG
LFCR
LFCR
Q4 25
22.01×
Q3 25
Q2 25
Q1 25
0.10×
Q4 24
Q3 24
Q2 24
Q1 24
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

Related Comparisons